2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) TherapyAlzheimer disease type 1, Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, cognitive disorder, psychiatric disorderActive, not recruitingEarly phase 12026-01-22NCT05469009
Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use DisorderChemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorderActive, not recruitingNot applicable2025-07-28NCT03950492